Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Structural properties of EGCG-induced, nontoxic Alzheimer's disease Aβ oligomers.
J. Mol. Biol. 421, 517-524 (2012)
The green tea compound epigallocatechin-3-gallate (EGCG) inhibits Alzheimer's disease beta-amyloid peptide (A beta) neurotoxicity. Solution-state NMR allows probing initial EGCG-A beta interactions. We show that EGCG-induced A beta oligomers adopt a well-defined structure and are amenable for magic angle spinning solid-state NMR investigations. We find that EGCG interferes with the aromatic hydrophobic core of A beta. The C-terminal part of the A beta peptide (residues 22-39) adopts a beta-sheet conformation, whereas the N-terminus (residues 1-20) is unstructured. The characteristic salt bridge involving residues D23 and K28 is present in the structure of these oligomeric A beta aggregates as well. The structural analysis of small-molecule-induced amyloid aggregates will open new perspectives for Alzheimer's disease drug development.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
4.001
1.187
116
141
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
Alzheimer's Disease ; Beta-amyloid Peptide ; Magic Angle Spinning (mas) Solid-state Nmr Spectroscopy ; Drug Development ; Neurotoxicity; Solid-State Nmr; Amyloid Fibrils; Green Tea; Experimental Constraints; Peptide; Toxicity; Inhibitors; (-)-Epigallocatechin-3-Gallate; Neurotoxicity; Spectroscopy
Sprache
englisch
Veröffentlichungsjahr
2012
HGF-Berichtsjahr
2012
ISSN (print) / ISBN
0022-2836
e-ISSN
1089-8638
Zeitschrift
Journal of Molecular Biology
Quellenangaben
Band: 421,
Heft: 4-5,
Seiten: 517-524
Verlag
Elsevier
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Structural Biology (STB)
POF Topic(s)
30203 - Molecular Targets and Therapies
30505 - New Technologies for Biomedical Discoveries
30505 - New Technologies for Biomedical Discoveries
Forschungsfeld(er)
Enabling and Novel Technologies
PSP-Element(e)
G-503090-001
G-503000-004
G-503000-004
PubMed ID
22300765
WOS ID
WOS:000308383800007
Scopus ID
84864281808
Erfassungsdatum
2012-09-27